These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. How Acute Kidney Injury Contributes to Renal Fibrosis. Yang L Adv Exp Med Biol; 2019; 1165():117-142. PubMed ID: 31399964 [TBL] [Abstract][Full Text] [Related]
5. Role of renin-angiotensin system in acute kidney injury-chronic kidney disease transition. Chou YH; Chu TS; Lin SL Nephrology (Carlton); 2018 Oct; 23 Suppl 4():121-125. PubMed ID: 30298669 [TBL] [Abstract][Full Text] [Related]
6. Biomarkers of renal function, which and when? Wasung ME; Chawla LS; Madero M Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004 [TBL] [Abstract][Full Text] [Related]
8. Cell Cycle Arrest as a Therapeutic Target of Acute Kidney Injury. Wang WG; Sun WX; Gao BS; Lian X; Zhou HL Curr Protein Pept Sci; 2017; 18(12):1224-1231. PubMed ID: 27634440 [TBL] [Abstract][Full Text] [Related]
9. AKI: an increasingly recognized risk factor for CKD development and progression. Kurzhagen JT; Dellepiane S; Cantaluppi V; Rabb H J Nephrol; 2020 Dec; 33(6):1171-1187. PubMed ID: 32651850 [TBL] [Abstract][Full Text] [Related]
10. The influence of multiple episodes of acute kidney injury on survival and progression to end stage kidney disease in patients with chronic kidney disease. Sykes L; Asar O; Ritchie J; Raman M; Vassallo D; Alderson HV; O'Donoghue DJ; Green D; Diggle PJ; Kalra PA PLoS One; 2019; 14(7):e0219828. PubMed ID: 31318937 [TBL] [Abstract][Full Text] [Related]
12. Subcellular trafficking of tubular MDM2 implicates in acute kidney injury to chronic kidney disease transition during multiple low-dose cisplatin exposure. Su H; Ye C; Lei CT; Tang H; Zeng JY; Yi F; Zhang C FASEB J; 2020 Jan; 34(1):1620-1636. PubMed ID: 31914692 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia as a key player in the AKI-to-CKD transition. Tanaka S; Tanaka T; Nangaku M Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1187-95. PubMed ID: 25350978 [TBL] [Abstract][Full Text] [Related]
14. Evolution of chronic renal impairment and long-term mortality after de novo acute kidney injury in the critically ill; a Swedish multi-centre cohort study. Rimes-Stigare C; Frumento P; Bottai M; Mårtensson J; Martling CR; Walther SM; Karlström G; Bell M Crit Care; 2015 May; 19(1):221. PubMed ID: 25944032 [TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction and the AKI-to-CKD transition. Jiang M; Bai M; Lei J; Xie Y; Xu S; Jia Z; Zhang A Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1105-F1116. PubMed ID: 33073587 [TBL] [Abstract][Full Text] [Related]
16. Long-term mortality and risk factors for development of end-stage renal disease in critically ill patients with and without chronic kidney disease. Rimes-Stigare C; Frumento P; Bottai M; Mårtensson J; Martling CR; Bell M Crit Care; 2015 Nov; 19():383. PubMed ID: 26526622 [TBL] [Abstract][Full Text] [Related]
17. [Identification of Biomarkers for Tubular Injury and Interstitial Fibrosis in Chronic Kidney Disease]. Nakagawa S Yakugaku Zasshi; 2017; 137(11):1355-1360. PubMed ID: 29093371 [TBL] [Abstract][Full Text] [Related]
18. Bidirectional relationships between acute kidney injury and chronic kidney disease. Pannu N Curr Opin Nephrol Hypertens; 2013 May; 22(3):351-6. PubMed ID: 23508059 [TBL] [Abstract][Full Text] [Related]
19. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury. Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709 [TBL] [Abstract][Full Text] [Related]
20. Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease Transition. Nangaku M; Hirakawa Y; Mimura I; Inagi R; Tanaka T Nephron; 2017; 137(4):256-259. PubMed ID: 28595179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]